Literature DB >> 3979238

Comparison of cimetidine and ranitidine on 24-hour intragastric acidity and serum gastrin profile in patients with esophagitis.

V Mahachai, K Walker, A B Thomson, L Zuk, P Kirdeikis, D Fisher, K Brunet.   

Abstract

Twenty-four-hour intragastric pH and serum gastrin profiles were monitored in six male asymptomatic patients who previously were found to have esophagitis on endoscopy and biopsy. They received cimetidine 300 mg qid (C), ranitidine 150 mg bid (R), or placebo (P) for one week each, utilizing the Latin-square design. The mean BAO was 0.4 +/- 0.2 mmol/hr, and the pentagastrin-stimulated MAO was 21.2 +/- 3.2 mmol/hr. In the P-treated patients, the pH fluctuated between 1.8 and 3.5 and over 90% of the readings were less than pH 4. As compared to P, both C and R significantly suppressed H+ after breakfast, overnight, and over the 24-hr period. The mean pH after lunch was significantly higher in R than in P, but not in C. Over the 24-hr period, a higher percentage of the readings were above pH 4.0 in R as compared to C. During the night, 50% of the pH readings were above pH 4.0 in C and R, whereas in P 50% of the pH readings were less than pH 2.0. The integrated gastrin responses after each meal were similar in C and R and were greater than in P. The biphasic response of the ratio of H+ and gastrin (H+/G) following each meal was suppressed by both H2-receptor antagonists, with numerically lower values obtained in R than in C. This study suggests that ranitidine 150 mg bid is superior to cimetidine 300 mg qid in suppressing the 24-hr intragastric acidity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3979238     DOI: 10.1007/bf01403840

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  10 in total

1.  THE DETERMINATION OF GASTRIC ACIDITY BY THE GLASS ELECTRODE.

Authors:  E W MOORE; R W SCARLATA
Journal:  Gastroenterology       Date:  1965-08       Impact factor: 22.682

2.  Effect of cimetidine on 24-hour intragastric acidity in normal subjects.

Authors:  R E Pounder; J G Williams; G J Milton-Thompson; J J Misiewicz
Journal:  Gut       Date:  1976-02       Impact factor: 23.059

3.  A modified hemoglobin substrate method for the estimation of pepsin in gastric juice.

Authors:  A Berstad
Journal:  Scand J Gastroenterol       Date:  1970       Impact factor: 2.423

4.  Comparison of ranitidine and cimetidine in the inhibition of histamine, sham-feeding, and meal-induced gastric secretion in duodenal ulcer patients.

Authors:  S J Konturek; W Obtulowicz; N Kwiecien; E Sito; E Mikos; J Oleksy
Journal:  Gut       Date:  1980-03       Impact factor: 23.059

5.  Ranitidine in the treatment of symptomatic gastroesophageal reflux disease.

Authors:  R Sherbaniuk; R Wensel; R Bailey; A Trautman; M Grace; P Kirdeikis; L Jewell; P Pare; D Levesque; A Farley
Journal:  J Clin Gastroenterol       Date:  1984-02       Impact factor: 3.062

6.  Mechanisms of gastroesophageal reflux in patients with reflux esophagitis.

Authors:  W J Dodds; J Dent; W J Hogan; J F Helm; R Hauser; G K Patel; M S Egide
Journal:  N Engl J Med       Date:  1982-12-16       Impact factor: 91.245

7.  Controlled trial of cimetidine in reflux esophagitis.

Authors:  R Fiasse; C Hanin; A Lepot; C Descamps; F Lamy; C Dive
Journal:  Dig Dis Sci       Date:  1980-10       Impact factor: 3.199

8.  Gastric secretion and emptying of liquids in reflex esophagitis.

Authors:  F Baldi; R Corinaldesi; F Ferrarini; V Stanghellini; M Miglioli; L Barbara
Journal:  Dig Dis Sci       Date:  1981-10       Impact factor: 3.199

9.  Comparison of the effects of ranitidine, cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer.

Authors:  R P Walt; P J Male; J Rawlings; R H Hunt; G J Milton-Thompson; J J Misiewicz
Journal:  Gut       Date:  1981-01       Impact factor: 23.059

10.  Gastrin, gastric emptying, and gastroesophageal reflux after ranitidine.

Authors:  R W Sherbaniuk; R Wensel; A Trautman; M Grace; B Lentle; K Walker; M Salkie; A B Thomson
Journal:  J Clin Gastroenterol       Date:  1983-06       Impact factor: 3.062

  10 in total
  6 in total

1.  Gastric enterochromaffin-like (ECL) cells in hypergastrinaemic duodenal ulcer disease.

Authors:  M Coupe; H Rees; C J Springer; A E Bishop; J A Morris; J M Polak; J Calam
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

2.  Influence of chronic omeprazole treatment on gastric endocrine function.

Authors:  H Koop; H Schwarting; A Knorr-Marin; C Willhardt; T Möser; R Arnold
Journal:  Klin Wochenschr       Date:  1987-02-16

Review 3.  Antisecretory and antigastrin effects of rioprostil in gastric fistula dogs.

Authors:  L B Katz; T Genna; G H Greeley; D A Shriver
Journal:  Dig Dis Sci       Date:  1987-11       Impact factor: 3.199

Review 4.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

5.  Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.

Authors:  W Inauen; C Emde; B Weber; D Armstrong; H U Bettschen; T Huber; U Scheurer; A L Blum; F Halter; H S Merki
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

6.  Does smoking interfere with the effect of histamine H2-receptor antagonists on intragastric acidity in man?

Authors:  P Bauerfeind; T Cilluffo; C J Fimmel; C Emde; C von Ritter; W Kohler; R Gugler; T Gasser; A L Blum
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.